More on XRAY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-30.8% Growth)
- Ratings (3.0 Score)
- Holders
- Dividends (5.5% Yield)
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/30/26)
- M&A (3/31/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

XRAY Cash Flow Statement

Click line-items for a historical chart and %
Net income 323.5M
Depreciation 87M
Amortization 109.9M
Deferred income taxes -102M
Share-based compensation expense 29.4M
Restructuring and other costs - noncash
Excess tax benefits from share-based compensation -11.3M
Accounts and notes receivable-trade, net -92.9M
Inventories, net 40.9M
Prepaid expenses and other current assets -22.7M
Accounts payable -1.4M
Accrued liabilities 2.5M
Income taxes payable -8.7M
Other, net
Net cash provided by operating activities 341M
Capital expenditures -79M
Cash paid for acquisitions of businesses, net of cash acquired -341.8M
Expenditures for identifiable intangible assets -1.1M
Proceeds from sale of property, plant and equipment, net 4.9M
Net cash used in investing activities 106.6M
Net change in short-term borrowings -47.7M
Cash paid for treasury stock -694.7M
Cash dividends paid -46.7M
Cash paid for contingent consideration on prior acquisitions
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries
Proceeds from long-term borrowings 840.7M
Repayments of long-term borrowings -503.2M
Proceeds from exercise of stock options 26.8M
Excess tax benefits from share-based compensation 11.3M
Net cash used in financing activities -413.5M
Effect of exchange rate changes on cash and cash equivalents 12M
Net increase(decrease) in cash and cash equivalents 46.1M
Cash and cash equivalents at beginning of period 284.6M
Cash and cash equivalents at end of period 330.7M